Research

Hormonal

Tirzepatide treatment, particularly during dose escalation, is associated with an increased risk of acute duodenal ulcer perforation in patients with pre-existing untreated Helicobacter pylori infection.

If you are taking tirzepatide and experience persistent or worsening stomach pain, nausea, or vomiting that does not resolve, do not assume it is just a normal side effect. Seek medical attention immediately, especially if you have a history of stomach issues or H. pylori. Early detection of ulcers can prevent perforation.

WeakSupportsVERY_LOW confidence
This case highlights the potential risk of duodenal perforation associated with tirzepatide, particularly in patients with untreated Helicobacter pylori infection. The patient's worsening gastrointestinal symptoms and perforation after initiating tirzepatide suggest a potential drug-related effect...
Maho Hayashi et al. · Cureus · 2025

Why this rating

Single case report; no control group; temporal association only.

Source

Acute Duodenal Ulcer Perforation Following Tirzepatide Treatment: A Case Report

Maho Hayashi et al. · Cureus · 2025

DOI 10.7759/cureus.80671

case_report · n=1Cited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →